There's a morose metaphor that seasoned drug developers often use to sum up decades of failed efforts to find treatments for Alzheimer's disease: They call the mind-robbing condition "the graveyard of drug development." But lately, sentiments have started to shift, with the arrival of Leqembi, a new drug approved by federal regulators in January.
CVS's announcement of its $10.6 billion deal for Oak Street Health (OSH) is just the latest example of how major healthcare players are slowly expanding their reach throughout different segments of the industry.
For four years, Kathryn Jackson has been filling prescriptions at her local pharmacy with no problems. But this month, Jackson and other Kaiser Permanente customers with prescriptions for maintenance medications received notice from the company they would need to switch to the company’s own mail-order pharmacy for refills if they wanted their prescriptions covered.
The Hague Pharmacy at Children’s Hospital of the King’s Daughters closed abruptly on Wednesday after its lease was terminated, leaving patients confused and worried about how they’ll get needed medications.
Under President Biden’s prescription drug law, drug companies will pay rebates to the federal government for raising prescription drug prices faster than the rate of inflation.